April 9, 2023 Comments Off on New patent expiration for Astrazeneca Ab drug BYDUREON PEN Posted in: General Biotechnology Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-two…
The post New patent expiration for Astrazeneca Ab drug BYDUREON PEN a…
October 12, 2022 Comments Off on New patent for Dermavant Sci drug VTAMA Posted in: General Biotechnology Annual Drug Patent Expirations for VTAMA Vtama is a drug marketed by Dermavant Sci and is included in one NDA. There are three patents protecting this drug. This drug has…
The post New patent for Dermavant Sci drug VTAMA appeared first on DrugPatentWat…